• 한국초전도학회:학술대회논문집
• /
• 한국초전도학회 2004년도 High Temperature Superconductivity Vol.XIV
• /
• pp.76-76
• /
• 2004

• 한국초전도학회:학술대회논문집
• /
• 한국초전도학회 2007년도 High Temperature Superconductivity Vol.XVII
• /
• pp.97-97
• /
• 2007

• 한국초전도학회:학술대회논문집
• /
• 한국초전도학회 2002년도 High Temperature Superconductivity Vol.XII
• /
• pp.64-64
• /
• 2002

• 한국세라믹학회:학술대회논문집
• /
• 한국세라믹학회 2003년도 추계총회 및 연구발표회 초록집
• /
• pp.171.2-171
• /
• 2003

• Bulletin of the Korean Chemical Society
• /
• 제31권12호
• /
• pp.3797-3799
• /
• 2010

• Bulletin of the Korean Chemical Society
• /
• 제27권1호
• /
• pp.147-149
• /
• 2006

• 한국재료학회:학술대회논문집
• /
• 한국재료학회 2002년도 추계학술발표강연 및 논문개요집
• /
• pp.91-91
• /
• 2002

• 한국재료학회:학술대회논문집
• /
• 한국재료학회 2002년도 추계학술발표강연 및 논문개요집
• /
• pp.103-103
• /
• 2002

• 한국세라믹학회지
• /
• 제39권8호
• /
• pp.783-788
• /
• 2002

본 연구에서는 TMS[Tetramethylsilane:Si($CH_3)_4$], $NH_3$와 $H_2$를 이용하여 나노크기의 Si-C-N precursor 분말을 합성하기 위하여 CVC법을 이용하였으며 반응온도, TMS/$NH_3$ 비 그리고 TMS/$H_2$ 비를 변화시켰다. XRD와 FESEM 분석을 통해서 결정상과 입자의 크기 그리고 입자의 형태를 관찰하고자 하였으며, 그 결과 제조된 분말은 모든 실험 조건하에서 87∼130 nm 크기를 지닌 균일한 구형의 비정질 분말이 얻어졌다. 입자 크기는 반응온도의 감소에 따라 감소하였으며, 또한 TMS/$NH_3$, TMS/$H_2$ 비가 작아질수록 감소하였다. EA 분석 결과 제조된 분말은 Si, N, C, H로 이루어졌음을 알 수 있었으며 FT-IR를 통하여 Si-N, C-N, Si-C 결합을 가진 Si-C-N precursor 분말이 제조되었다

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권1호
• /
• pp.45-51
• /
• 2015

Background: The current study examined health-related quality of life (QoL) for patients with esophageal/gastric cardia precursor lesions or cancer before and after treatment to facilitate improved prevention and treatment. Materials and Methods: Patients with different stages of esophageal/gastric cardia lesions completed two QoL questionnaires, EORTC QLQ-C30 and supplemental QLQ-OES 18, before primary treatment, and at 1, 6 and 12 months after treatment. Results: Fifty-nine patients with precursor lesions, 57 with early stage cancer, and 43 with advanced cancer responded to our survey. Patients with precursor lesions or early stage cancer reported better QoL overall than those with advanced cancer before treatment (p<0.01). Global QoL scores before treatment and at 1 month after treatment were $71{\pm}9$ versus $69{\pm}9$ (p>0.01), $71{\pm}8$ versus $61{\pm}11$ (p<0.01), $67{\pm}11$ versus $62{\pm}9$ (p<0.01) for three stages of lesions. At 6 months after treatment, some QoL measures recovered gradually in precursor lesion and early cancer patients, while some continuously deteriorated in advanced cancer patients. At 12 months, all QoL scores were comparable to baseline for patients with precursor lesions (p>0.01), while global QoL, social, pain, and insomnia scores for early stage and advanced cancer were inferior to corresponding baseline levels (difference between means>5, p<0.01). At this time point, compared with patients with early stage cancer, those with advanced cancer showed worse QoL with all function and most symptom measures (p<0.01). Conclusions: Patients with precursor lesions or early stage esophageal/gastric cardia cancer show better QoL than those with advanced cancer. This indicates that screening, early diagnosis and treatment may improve the QoL for esophageal/gastric cardia cancer patients. Target intervention and counseling should be given by health care providers during treatment and follow-up to facilitate QoL improvement.